ACTU

COM:ACTUATETHERAPEUTICS

Actuate Therapeutics

Stock

USD

Last Close

8.98

22/11 21:00

Market Cap

195.32M

Beta: -

Volume Today

30.74K

Avg: -

Overview Metrics Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Mar '24	Jun '24	Sep '24
net income	-8.30M -	-6.57M 20.78%	-5.97M 9.15%
depreciation and amortization
deferred income tax
stock based compensation	148.21K -	90.02K 39.26%	565.98K 528.74%
change in working capital	2.36M -	2.66M 12.72%	-4.40M 265.32%
accounts receivables
inventory
accounts payables	483.70K -	1.93M 298.75%	-3.61M 287.18%
other working capital	1.88M -	734.39K 60.92%	-792.56K 207.92%
other non cash items	537.59K -	1.15M 113.06%	658.73K 42.49%
net cash provided by operating activities	-5.25M -	-2.67M 49.05%	-9.15M 242.19%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment	4.50M -	1M 77.78%
common stock issued
common stock repurchased
dividends paid
other financing activites	-142.77K -	-42.96K 69.91%	22.32M 52,057.06%
net cash used provided by financing activities	4.36M -	957.04K 78.04%	22.32M 2,232.27%
effect of forex changes on cash
net change in cash	-890.35K -	-1.72M 92.80%	13.17M 867.32%
cash at beginning of period	2.96M -	2.07M 30.09%	351.71K 83.00%
cash at end of period	2.07M -	351.71K 83.00%	13.52M 3,745.07%
operating cash flow	-5.25M -	-2.67M 49.05%	-9.15M 242.19%
capital expenditure
free cash flow	-5.25M -	-2.67M 49.05%	-9.15M 242.19%

All numbers in USD (except ratios and percentages)